1.Drevets, WC, Price, JL, Simpson, JR Jr, et al.Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824–827.
2.Mazziotta, JC, Phelps, ME, Plummer, D, Kuhl, DE. Quantitation in positron emission computed tomography: 5. Physical—anatomical effects. J Comput Assist Tomogr. 1981;5:734–743.
3.Ongür, D, Drevets, WC, Price, JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA. 1998;95:13290–13295.
4.Ongür, D, Ferry, AT, Price, JL. Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol. 2003;460:425–449.
5.Botteron, KN, Raichle, ME, Drevets, WC, Heath, AC, Todd, RD. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol Psychiatry. 2002;51:342–344.
6.Hirayasu, Y, Shenton, ME, Salisbury, DF, et al.Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry. 1999;156:1091–1093.
7.Drevets, WC, Ryan, N, Bogers, W, Birmaher, B, Axelson, D, Dahl, R. Subgenual prefrontal cortex volume decreased in healthy humans at high familial risk for mood disorders. Abstract presented at. Annual Meeting Of The Society For Neuroscience. October 23, 2007; San Diego, Calif.
8.Boes, AD, McCormick, LM, Coryell, WH, Nopoulos, P. Rostral anterior cingulate cortex volume correlates with depressed mood in normal healthy children. Biol Psychiatry. 2007;63:391–397.
9.Hastings, RS, Parsey, RV, Oquendo, MA, Arango, V, Mann, JJ. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology. 2004;29:952–959.
10.Coryell, W, Nopoulos, P, Drevets, W, Wilson, T, Andreasen, NC. Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. Am J Psychiatry. 2005;162:1706–1712.
11.Adler, CM, DelBello, MP, Jarvis, K, Levine, A, Adams, J, Strakowski, SM. Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry. 2006;61:776–781.
12.Haznedar, MM, Roversi, F, Pallanti, S. Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Biol Psychiatry. 2005;57:733–742.
13.Drevets, WC, Gadde, K. Krishnan, KRR. Neuroimaging studies of depression. In: Charney, DS, Nestler, EJ, Bunney, BJ, eds. The Neurobiological Foundation Of Mental Illness. 2nd ed. New York, NY: Oxford University Press; 2004:461–490.
14.Drevets, WC, Videen, TO, Price, JL, Preskorn, SH, Carmichael, ST, Raichle, ME. A functional anatomical study of unipolar depression. J Neurosci. 1992;12:3628–3641.
15.Wu, J, Buchsbaum, MS, Gillin, JC, et al.Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry. 1999;156:1149–58.
16.Mayberg, HS, Brannan, SK, Tekell, JL, et al.Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000;48:830–843.
17.Kennedy, SH, Evans, KR, Krüger, S. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry. 2001;158:899–905.
18.Drevets, WC, Bogers, W, Raichle, ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol. 2002;12:527–544.
19.Dunn, RT, Kimbrell, TA, Ketter, TA, et al.Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry. 2002;51:387–399.
20.Liotti, M, Mayberg, HS, McGinnis, S, Brannan, SL, Jerabek, RUnmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry. 2002;159:1830–1840.
21.Winokur, G, Coryell, W. Familial subtypes of unipolar depression: a prospective study of familial pure depressive disease compared to depression spectrum disease. Biol Psychiatry. 1992;32:1012–1018.
22.Smith, GS, Kramer, E, Hermann, CR, et al.Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. Am J Geriatr Psychiatry. 2002;10:715–723.
23.Davidson, RJ, Irwin, W, Anderle, MJ, Kalin, NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry. 2003;160:64–75.
24.Kegeles, LS, Malone, KM, Slifstein, M, et al.Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders. Am J Psychiatry. 2003;160:76–82.
25.Holthoff, VA, Beuthien-Baumann, B, Zündorf, G, et al.Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand. 2004;110:184–94.
26.Pizzagalli, DA, Oakes, TR, Fox, AS, et al.Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry. 2004;9:325, 393–405.
27.Gotlib, IH, Sivers, H, Gabrieli, JD, et al.Subgenual anterior cingulate activation to valenced emotional stimuli in major depression. Neuroreport. 2005;16:1731–1734.
28.Mayberg, HS, Lozano, AM, Voon, V, et al.Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–660.
29.Drevets, W, Spitznagel, E, Raichle, M. Functional anatomical differences between major depressive subtypes. J Cereb Blood Flow Metab. 1995;15:S93
30.Clark, CP, Brown, GG, Frank, L, Thomas, L, Sutherland, AN, Gillin, JC. Improved anatomic delineation of the antidepressant response to partial sleep deprivation in medial frontal cortex using perfusion-weighted functional MRI. Psychiatry Res. 2006;146:213–222.
31.Kumano, H, Ida, I, Oshima, A, et al.Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients—a preliminary PET study. J Psychiatr Res. 2006;41:591–599.
32.Chen, CH, Ridler, K, Suckling, J, et al.Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry. 2007:62:407–414.
33.Nahas, Z, Teneback, C, Chae, JH, et al.Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology. 2007;32:1649–1660.
34.Savitz, J, Drevets, WC. Bipolar and Major Depressive Disorder: Neuroimaging the Developmental-Degenerative Divide; Neuroscience and Biobehavioral Reviews, In press
35.Talairach, J, Tournoux, P. Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart, Germany: Thieme; 1988.
36.Blumberg, HP, Stern, E, Martinez, D, et al.Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry. 2000;48:1045–1052.
37.Ketter, TA, Kimbrell, TA, George, MS, et al.Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry. 2001;49:97–109.
38.Drevets, WC, Bogers, W, Raichle, ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol. 2002;12:527–544.
39.Krüger, S, Seminowicz, D, Goldapple, K, et al.State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biol Psychiatry. 2003;54:1274–1283.
40.Lennox, BR, Jacob, R, Calder, AJ, Lupson, V, Bullmore, ET. Behavioural and neurocognitive responses to sad facial affect are attenuated in patients with mania. Psychol Med. 2004;34:795–802.
41.Bauer, M, London, ED, Rasgon, N, et al.Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry. 2005;10:456–469.
42.McDonald, C, Bullmore, ET, Sham, PC, et al.Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry. 2004;61:974–984.
43.Rich, BA, Vinton, DT, Roberson-Nay, R, et al.Limbic hyperactivation during processing of neutral facial expressions in children with bipolar disorder. Proc Natl Acad Sci USA. 2006;103:8900–8905.
44.Haldane, M, Jogia, J, Cobb, A, Kozuch, E, Kumari, V, Frangou, S. Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with Lamotrigine monotherapy. Eur Neuropsychopharmacol. 2008;18:48–54.
45.Mah, L, Zarate, CA Jr, Singh, J, et al.Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biol Psychiatry. 2007;61:765–775.
46.Moore, G, Cortese, B, Glitz, D, et al.Lithium increases gray matter in the prefrontal and subgenual prefrontal cortices in treatment responsive bipolar patients. J Clin Psychiatry. In press.
47.Bearden, CE, Thompson, PM, Dalwani, M, et al.Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry. 2007;62:7–16.
48.Shah, PJ, Ebmeier, KR, Glabus, MF, Goodwin, GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry. 1998;172:527–532.
49.Bremner, JD, Vythilingam, M, Vermetten, E. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry. 2002;51:273–279.
50.Caetano, SC, Kaur, S, Brambilla, P. Smaller cingulate volumes in unipolar depressed patients. Biol Psychiatry. 2006;59:702–706.
51.Tang, Y, Wang, F, Xie, G, et al.Reduced ventral anterior cingulate and amygdala volumes in medication-naïve females with major depressive disorder: a voxel-based morphometric magnetic resonance imaging study. Psychiatry Res. 2007;156:83–86.
52.Moore, GJ, Bebchuk, JM, Wilds, IB, Chen, G, Manji, HK. Lithium-induced increase in human brain grey matter. Lancet. 2000;356:1241–1242.
53.Brambilla, P, Nicoletti, MA, Harenski, K, et al.Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects. Neuropsychopharmacology. 2002;27:792–779.
54.Sharma, V, Menon, R, Carr, TJ, Densmore, M, Mazmanian, D, Williamson, PC. An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder. J Affect Disord. 2003;77:167–171.
55.Bruno, SD, Barker, GJ, Cercignani, M, Symms, M, Ron, MA. A study of bipolar disorder using magnetization transfer imaging and voxel-based morphometry. Brain. 2004;127:2433–2440.
56.Doris, A, Belton, E, Ebmeier, KP, Glabus, MF, Marshall, I. Reduction of cingulate gray matter density in poor outcome bipolar illness. Psychiatry Res. 2004;130:153–159.
57.Lochhead, RA, Parsey, RV, Oquendo, MA, Mann, JJ. Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry. Biol Psychiatry. 2004;55:1154–1162.
58.Kaur, S, Sassi, RB, Axelson, D, et al.Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. Am J Psychiatry. 2005;162:1637–1643.
59.Sanches, M, Sassi, RB, Axelson, D, et al.Subgenual prefrontal cortex of child and adolescent bipolar patients: a morphometric magnetic resonance imaging study. Psychiatry Res. 2005;138:43–49.
60.Zimmerman, ME, DelBello, MP, Getz, GE, Shear, PK, Strakowski, SM. Anterior cingulate subregion volumes and executive function in bipolar disorder. Bipolar Disord. 2006;8:281–288.
61.Chiu, S, Widjaja, F, Bates, ME, et al.Anterior cingulate volume in pediatric bipolar disorder and autism. J Affect Disord. 2007;105:93–99.
62.Nugent, AC, Milham, MP, Bain, EE, et al.Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage. 2006;30:485–497.
63.Phillips, ML, Drevets, WC, Rauch, SL, Lane, R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry. 2003;54:515–528.
64.Cotter, D, Mackay, D, Landau, S, Kerwin, R, Everall, I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry. 2001;58:545–553.
65.Rajkowska, G, Miguel-Hidalgo, JJ, Wei, J, et al.Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 1999;45:1085–1098.
66.Cotter, D, Mackay, D, Chana, G, Beasley, C, Landau, S, Everall, IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex. 2002;12:386–394.
67.Uranova, NA, Vostrikov, VM, Orlovskaya, DD, Rachmanova, VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res. 2004;67:269–275.
68.Bowley, MP, Drevets, WC, Ongür, D, Price, JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry. 2002;52:404–412.
69.Hamidi, M, Drevets, WC, Price, JL. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry. 2004;55:563–569.
70.George, MS, Ketter, TA, Parekh, PI, Horwitz, B, Herscovitch, P, Post, RM. Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry. 1995;152:341–351..
71.Mayberg, HS, Liotti, M, Brannan, SK, et al.Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156:675–682.
72.Rauch, SL, Drevets, WC. Neuroimaging and the neuroanatomy of stress-induced and fear circuitry disorders: the agenda for future research. In: Andrews, G, Charney, DS, Sirovatka, PJ, Regier, DA, eds. Stress-Induced and Fear Circuitry Disorders: Refining the Research Agenda for DSM-V. Washington, DC: American Psychiatric Association; 2008;235–278.
73.Elliott, R, Rubinsztein, JS, Sahakian, BJ, Dolan, RJ. Selective attention to emotional stimuli in a verbal go/no-go task: an fMRI study. Neuroreport. 2000;11:1739–1744.
74.Gillath, O, Bunge, SA, Shaver, PR, Wendelken, C, Mikulincer, M. Attachment-style differences in the ability to suppress negative thoughts: exploring the neural correlates. Neuroimage. 2005;28:835–847.
75.Phelps, EA, Delgado, MR, Nearing, KI, LeDoux, JE. Extinction learning in humans: role of the amygdala and vmPFC. Neuron. 2004;43:897–905.
76.Drevets, WC, Ongür, D, Price, JL. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry. 1998;3:220–226, 190–191.
77.Bush, G, Luu, P, Posner, MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci. 2000;4:215–222.
78.Critchley, HD, Mathias, CJ, Josephs, O, et al.Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. Brain. 2003;126(pt 10):2139–252.
79.Osuch, EA, Ketter, TA, Kimbrell, TA, et al.Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry. 2000;48:1020–1023.
80.Mayberg, HS, Brannan, SK, Mahurin, RK, et al.Cingulate function in depression: a potential predictor of treatment response. Neuroreport. 1997;8:1057–1061.
81.Kumano, H, Ida, I, Oshima, A, Takahashi, K, Yuuki, N, et al.Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patient-a preliminary PET study. J Psychiatr Res. 2007;41:591–599.
82.Inagaki, M, Yoshikawa, E, Kobayakawa, M, et al.Regional cerebral glucose metabolism in patients with secondary depressive episodes after fatal pancreatic cancer diagnosis. J Affect Disord. 2007;99:231–236.
83.Drevets, WC, Price, JL. Neuroimaging and neuropathological studies of mood disorders. In: Licinio, J, Wong, M-L, eds. Biology Of Depression: From Novel Insights To Therapeutic Strategies. Weinheim, Germany: Wiley-Vch Verlag Gmbh & Co; 2005:427–466.
84.Neumeister, A, Nugent, AC, Waldeck, T, et al.Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry. 2004;61:765–773.
85.Hasler, G, Fromm, S, Carlson, PJ, et al.Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry. 2008;65:521–531.
86.Nobler, MS, Oquendo, MA, Kegeles, LS, et al.Decreased regional brain metabolism after ect. Am J Psychiatry. 2001;158:305–308.
87.Manji, HK, Drevets, WC, Charney, DS. The cellular neurobiology of depression. Nat Med. 2001;7:541–547.
88.Banasr, M, Duman, RS. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. Cns Neurol Disord Drug Targets. 2007;6:311–320.
89.Czéh, B, Simon, M, Schmelting, B, Hiemke, C, Fuchs, E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology. 2005;31:1616–1626.
90.McEwen, BS, Magarinos, AM. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol. 2001;16(S1):S7–S19.
91.Wellman, CL. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol. 2001;49:245–253.
92.Radley, JJ, Rocher, AB, Rodriguez, A, et al.Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex. J Comp Neurol. 2008;507:1141–1150.
93.Drevets, WC, Furey, ML. Emotional disorders: depression and the brain. In: Squire, L, ed. The New Encyclopedia of Neuroscience. 4th ed. New York, NY: Elsevier Publishing, Inc; In press.
94.Drevets, WC, Price, JL, Bardgett, ME, Reich, T, Todd, RD, Raichle, ME. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma Cortisol levels. Pharmacol Biochem Behav. 2002:71:431–447.
95.Shulman, RG, Rothman, DL, Behar, KL, Hyder, F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci. 2004;27:489–495.
96.Diorio, D, Viau, V, Meaney, MJ. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci. 1993;13:3839–3847.
97.Pezawas, L, Meyer-Lindenberg, A, Drabant, EM, et al.5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci. 2005;8:828–834.
98.Caspi, A, Sugden, K, Moffitt, TE, et al.Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003:301:386–389.
99.Stockmeier, CA, Mahajan, GJ, Konick, LC, et al.Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry. 2004;56:640–650.
100.Eastwood, SL, Harrison, PJ. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry. 2000;5:425–432.
101.Rosoklija, G, Toomayan, G, Ellis, SP, et al.Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry. 2000:57:349–356.
102.Drevets, WC, Wymore, AC, Bain, E, et al.Neuromorphometric MRI assessments of the hippocampal subiculum in mood disorders. Biol Psychiatry. 2003;53:189S.
103.Baumann, B, Danos, P, Krell, D, et al.Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci. 1999;11:71–78.
104.Morgan, MA, LeDoux, JE. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci. 1995;109:681–688.
105.Frysztak, RJ, Neafsey, EJ. The effect of medial frontal cortex lesions on cardiovascular conditioned emotional responses in the rat. Brain Res. 1994;643:181–193.
106.Sullivan, RM, Gratton, A. Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats. J Neurosci. 1999;19:2834–2840.
107.Carney, RM, Freedland, KE, Veith, RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med. 2005;67(suppl 1):S29–S33.
108.Ongür, D, Price, JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000;10:206–219.
109.Bechara, A, Damasio, AR, Damasio, H, Anderson, SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7–15.
110.Damasio, AR. Descarte's Error: Emotion, Reason, and the Human Brain. New York, NY: G.P. Putnam's Sons; 1995.
111.Schultz, W. Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol. 1997;7:191–197.